Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Supplements in Critically Ill Patients
NCT00515736Phase 3Terminated
- Sponsor
- Lausanne University Hospital
- Start
- Jan 2003
- Primary completion
- Dec 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of selenium, zinc, ascorbic acid, thiamine and vitamin e in critical illness, cardiac surgery, psychological trauma and 1 more (2 arms), sponsored by Lausanne University Hospital. Primary endpoints: Organ function (Sequential Organ Failure Assessment) at 3 months and Renal function at 3 months. Started Jan 2003; status: terminated.
02
Drugs
seleniumzincascorbic acidthiaminevitamin e
03
Conditions
critical illnesscardiac surgerypsychological traumasubarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00515736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515736.